methylene blue has been researched along with epoxomicin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alfano, G; Brindisi, M; Brogi, S; Butini, S; Caldelari, R; Campiani, G; Chemi, G; D'Alessandro, S; Dechering, KJ; Fusi, F; Gemma, S; Gorelli, B; Jez, JM; Koolen, KJM; Lamponi, S; Lee, SG; Parapini, S; Saponara, S; Taramelli, D; Vallone, A | 1 |
Andrews, KT; Antonova-Koch, Y; Avery, VM; Diedrich, D; Duffy, S; Fisher, G; Gebru, T; Hansen, FK; Held, J; Hesping, E; Kurz, T; Meister, S; Schöler, A; Stenzel, K; Winzeler, EA | 1 |
2 other study(ies) available for methylene blue and epoxomicin
Article | Year |
---|---|
Antimalarial agents against both sexual and asexual parasites stages: structure-activity relationships and biological studies of the Malaria Box compound 1-[5-(4-bromo-2-chlorophenyl)furan-2-yl]-N-[(piperidin-4-yl)methyl]methanamine (MMV019918) and analog
Topics: Antimalarials; Dose-Response Relationship, Drug; Enzyme Inhibitors; Furans; Life Cycle Stages; Malaria, Falciparum; Methyltransferases; Molecular Structure; Parasitic Sensitivity Tests; Piperidines; Plasmodium falciparum; Structure-Activity Relationship | 2018 |
One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites.
Topics: Acetylation; Antimalarials; Hep G2 Cells; Histone Deacetylase Inhibitors; Histones; Humans; Malaria, Falciparum; Peptoids; Plasmodium falciparum; Protozoan Proteins | 2018 |